Rang	Name	Position
1	Mr. Gregory D. Perry	Chief Financial Officer
2	Mr. Peter B. Silverman J.D.	EVP, Company Secretary, COO, General Counsel, Chief Intellectual Property Officer & Head of US Legal
3	Dr. Fabian Zohren M.D., Ph.D.	Chief Medical Officer
4	Dr. Jan G.J. van de Winkel Ph.D.	CEO & Executive Director
5	Dr. Hennie Hoogenboom	Co-Founder and Scientific Advisor
6	Mr. Harry Shuman	Chief Accounting Officer
7	Mr. Cornelis Adriaan de Kruif Ph.D.	CTO & Executive VP
8	Dr. Cecilia Anna Wilhelmina Geuijen Ph.D.	Chief Scientific Officer & Senior VP
9	Ms. Sherri Spear	Senior Vice President of Investor Relations & Strategic Communications
10	Ms. Kathleen Farren	Director of IR & Corporate Communications Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	FMR Inc	9,90%	0,68 Mrd. USD
2	Paradigm Biocapital Advisors LP	5,66%	0,39 Mrd. USD
3	RTW INVESTMENTS, LLC	5,29%	0,36 Mrd. USD
4	Wellington Management Company LLP	4,93%	0,34 Mrd. USD
5	COMMODORE CAPITAL LP	4,66%	0,32 Mrd. USD
6	Deerfield Management Co	4,47%	0,31 Mrd. USD
7	venBio Select Advisor LLC	4,17%	0,29 Mrd. USD
8	T. Rowe Price Associates, Inc.	2,99%	0,20 Mrd. USD
9	Holocene Advisors, LP	2,94%	0,20 Mrd. USD
10	Westfield Capital Management Company, L.P.	2,70%	0,18 Mrd. USD
11	Franklin Resources Inc	2,43%	0,17 Mrd. USD
12	Polar Capital Holdings PLC	2,13%	0,15 Mrd. USD
13	Woodline Partners LP	2,04%	0,14 Mrd. USD
14	Federated Hermes Inc	2,02%	0,14 Mrd. USD
15	Driehaus Capital Management LLC	1,81%	0,12 Mrd. USD
16	Ameriprise Financial Inc	1,50%	0,10 Mrd. USD
17	Cormorant Asset Management, LLC	1,48%	0,10 Mrd. USD
18	AllianceBernstein L.P.	1,46%	0,10 Mrd. USD
19	Rock Springs Capital Management LP	1,41%	0,10 Mrd. USD
20	BlackRock Inc	1,39%	0,10 Mrd. USD